[go: up one dir, main page]

HUP0300290A2 - Érkárosító hatású kombinácíós készítmény és terápia - Google Patents

Érkárosító hatású kombinácíós készítmény és terápia

Info

Publication number
HUP0300290A2
HUP0300290A2 HU0300290A HUP0300290A HUP0300290A2 HU P0300290 A2 HUP0300290 A2 HU P0300290A2 HU 0300290 A HU0300290 A HU 0300290A HU P0300290 A HUP0300290 A HU P0300290A HU P0300290 A2 HUP0300290 A2 HU P0300290A2
Authority
HU
Hungary
Prior art keywords
subject
combination therapies
platinum
warm
production
Prior art date
Application number
HU0300290A
Other languages
English (en)
Inventor
Peter David Davis
Graeme Dougherty
Original Assignee
Angiogene Pharmaceuticals Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0007740A external-priority patent/GB0007740D0/en
Priority claimed from GB0013927A external-priority patent/GB0013927D0/en
Priority claimed from GB0014908A external-priority patent/GB0014908D0/en
Application filed by Angiogene Pharmaceuticals Ltd. filed Critical Angiogene Pharmaceuticals Ltd.
Publication of HUP0300290A2 publication Critical patent/HUP0300290A2/hu
Publication of HUP0300290A3 publication Critical patent/HUP0300290A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Glass Compositions (AREA)

Abstract

A találmány tárgyát képezi az (1) képletű ZD6126 vagy gyógyászatilagalkalmazható sója és egy platina típusú tumorellenes szer vagy egytaxán felhasználása melegvérűeken, köztük embereken érkárosító hatástelőidéző gyógyszerek gyártásához. A találmány tárgyát képezi továbbá aZD6126 vagy gyógyászatilag alkalmazható sójának felhasználása ionizálóbesugárzással kezelt melegvérűeken, köztük embereken érkárosító hatástelőidéző gyógyszerek gyártásához. A találmány tárgya továbbákombinációs termék, gyógyszerkészlet vagy gyógyászati készítmény, amiZD6126-ot vagy gyógyászatilag alkalmazható sóját és egy platina típusútumorellenes szert vagy egy taxánt tartalmaz, adott esetbengyógyászati célokra alkalmas excipienssel és/vagy hordozóanyaggalegyesítve. Ó
HU0300290A 2000-03-31 2001-03-27 Combination therapies with vascular damaging activity HUP0300290A3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0007740A GB0007740D0 (en) 2000-03-31 2000-03-31 Combination therapy
GB0013927A GB0013927D0 (en) 2000-06-08 2000-06-08 Combination therapy
GB0014908A GB0014908D0 (en) 2000-06-20 2000-06-20 Combination therapy
PCT/GB2001/001317 WO2001074368A1 (en) 2000-03-31 2001-03-27 Combination therapies with vascular damaging activity

Publications (2)

Publication Number Publication Date
HUP0300290A2 true HUP0300290A2 (hu) 2003-06-28
HUP0300290A3 HUP0300290A3 (en) 2005-12-28

Family

ID=27255634

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0300290A HUP0300290A3 (en) 2000-03-31 2001-03-27 Combination therapies with vascular damaging activity

Country Status (23)

Country Link
US (2) US6906048B2 (hu)
EP (1) EP1272199B1 (hu)
JP (1) JP2003528920A (hu)
KR (1) KR20020087456A (hu)
CN (1) CN1430515A (hu)
AT (1) ATE287267T1 (hu)
AU (2) AU2001242581B2 (hu)
BR (1) BR0109672A (hu)
CA (1) CA2402539A1 (hu)
CZ (1) CZ20023228A3 (hu)
DE (1) DE60108489T2 (hu)
EE (1) EE200200565A (hu)
ES (1) ES2236199T3 (hu)
HU (1) HUP0300290A3 (hu)
IL (1) IL151628A0 (hu)
IS (1) IS6558A (hu)
MX (1) MXPA02009604A (hu)
NO (1) NO20024646L (hu)
NZ (1) NZ521025A (hu)
PL (1) PL366379A1 (hu)
PT (1) PT1272199E (hu)
SK (1) SK13912002A3 (hu)
WO (1) WO2001074368A1 (hu)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070021392A1 (en) * 2000-03-31 2007-01-25 Davis Peter D Divided dose therapies with vascular damaging activity
GB0011903D0 (en) * 2000-05-18 2000-07-05 Astrazeneca Ab Combination chemotherapy
FR2834641B1 (fr) * 2002-01-14 2005-04-22 Ct Regional De Lutte Contre Le Protection de la neurotoxicite de l'oxaliplatine par administration de calcium et de magnesium
KR20040103964A (ko) * 2002-04-16 2004-12-09 아스트라제네카 아베 암 치료를 위한 조합 요법
GB0223379D0 (en) * 2002-10-09 2002-11-13 Angiogene Pharm Ltd Combination therapy
FR2848212B1 (fr) * 2002-12-06 2006-10-27 Aventis Pharma Sa Derives de la colchicine, procede de preparation, produits obtenus par ce procede et utilisation
CA2529409A1 (en) * 2003-06-18 2004-12-29 Angiogene Pharmaceuticals Limited Compositions comprising zd6126 together with 5-fu, cpt-11 or 5-fu and cpt-11 having vascular damaging activity for treating e.g. colorectal cancer
GB0316123D0 (en) * 2003-07-10 2003-08-13 Astrazeneca Ab Combination therapy
US9149489B2 (en) * 2006-04-27 2015-10-06 Board Of Regents, University Of Texas System Inhibitors of glycolysis useful in the treatment of brain tumors
US8178564B2 (en) * 2006-11-06 2012-05-15 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168662B1 (en) 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168661B2 (en) * 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8173686B2 (en) 2006-11-06 2012-05-08 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US20110033528A1 (en) * 2009-08-05 2011-02-10 Poniard Pharmaceuticals, Inc. Stabilized picoplatin oral dosage form
US20100260832A1 (en) * 2007-06-27 2010-10-14 Poniard Pharmaceuticals, Inc. Combination therapy for ovarian cancer
TW200916094A (en) * 2007-06-27 2009-04-16 Poniard Pharmaceuticals Inc Stabilized picoplatin dosage form
US20100310661A1 (en) * 2007-07-16 2010-12-09 Poniard Pharmaceuticals, Inc. Oral formulations for picoplatin
CA2715348A1 (en) * 2008-02-08 2009-08-13 Poniard Pharmaceuticals, Inc. Use of picoplatin and bevacizumab to treat colorectal cancer
TWI492759B (zh) * 2008-03-05 2015-07-21 Otsuka Pharma Co Ltd 膽甾烷醇衍生物之併用用途
PL2310020T3 (pl) 2008-07-11 2017-10-31 Univ Texas Nowe octany 2-deoksymonosacharydów o aktywności przeciwnowotworowej
KR101106214B1 (ko) * 2011-04-04 2012-01-20 홍오성 감귤 내껍질 분리 장치
EP2981270B1 (en) 2013-04-05 2021-08-25 Board of Regents, The University of Texas System Esters of 2-deoxy-monosaccharides with anti proliferative activity

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9714249D0 (en) 1997-07-08 1997-09-10 Angiogene Pharm Ltd Vascular damaging agents
JP2002518341A (ja) * 1998-06-15 2002-06-25 アーチ・デヴェロップメント・コーポレイション 放射線療法と抗血管形成因子の組み合わせ
GB9903404D0 (en) 1999-02-16 1999-04-07 Angiogene Pharm Ltd Methods of treatment and compositions useful for the treatment of diseases involving angiogenesis
MXPA02009603A (es) 2000-03-31 2004-05-14 Angiogene Pharm Ltd Terapias de dosis divididas con actividad de deterioro vascular.

Also Published As

Publication number Publication date
CN1430515A (zh) 2003-07-16
AU2001242581B2 (en) 2005-03-03
ES2236199T3 (es) 2005-07-16
EP1272199A1 (en) 2003-01-08
AU4258101A (en) 2001-10-15
BR0109672A (pt) 2003-02-04
EE200200565A (et) 2004-06-15
EP1272199B1 (en) 2005-01-19
IS6558A (is) 2002-09-20
DE60108489T2 (de) 2006-03-30
NO20024646L (no) 2002-10-15
HUP0300290A3 (en) 2005-12-28
PT1272199E (pt) 2005-05-31
CZ20023228A3 (cs) 2003-01-15
ATE287267T1 (de) 2005-02-15
NZ521025A (en) 2005-06-24
JP2003528920A (ja) 2003-09-30
US20050107346A1 (en) 2005-05-19
KR20020087456A (ko) 2002-11-22
IL151628A0 (en) 2003-04-10
SK13912002A3 (sk) 2003-05-02
DE60108489D1 (de) 2005-02-24
US20030166617A1 (en) 2003-09-04
CA2402539A1 (en) 2001-10-11
NO20024646D0 (no) 2002-09-27
US6906048B2 (en) 2005-06-14
PL366379A1 (en) 2005-01-24
WO2001074368A1 (en) 2001-10-11
MXPA02009604A (es) 2003-03-10

Similar Documents

Publication Publication Date Title
HUP0300290A2 (hu) Érkárosító hatású kombinácíós készítmény és terápia
CY1118849T1 (el) Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης
DE69921138D1 (de) Arzneimittel freisetzendes system enthaltend ein homeobox-peptid und ein zytotoxisches oder antineoplastisches mittel
CY1107838T1 (el) Παραγωγα αδαμαντανιου για τη θεραπεια φλεγμονωδων, ανοσολογικων και καρδιαγγειακων ασθενειων
AR023972A1 (es) Composiciones de medicamentos a base de compuestos anticolinergicamente activos y beta-mimeticos
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
CY1105707T1 (el) Συνδυασμοι φορμοτερολης και ενος αλατος τριοτροπιου
MXPA03010402A (es) Derivados de 4-amino-5-fenil-7-ciclobutil-pirrolo (2,3-d) pirimidina.
HUP0104709A2 (hu) Eritropoietin vagy eritropoietrinszármazékok alkalmazása agyi iszkémiák kezelésére használható gyógyszer előállítására
HK1085667A1 (en) Non-nucleoside reverse transcriptase inhibitors
NO993520L (no) Doseringsformer og fremgangsmÕte for Õ bedre erektil dysfunksjon
DE60115029D1 (de) Pharmazeutische zusammensetzungen enthaltend cannabidiol-derivate
HUP0000299A1 (hu) Késleltetett hatóanyag-leadású gyógyszerkészítmények
ES2092890T3 (es) Aplicacion del riluzol en el tratamiento de la enfermedad de parkinson y de los sindromes de parkinson.
IS7006A (is) Tvívetnis 3-piperidínóprópíófenon og lyf sem innihalda téð efnasambönd
DE69426334D1 (de) Parenterales Busulfan zur Behandlung von malignen Krankheiten
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
HUP0202671A2 (hu) Ketotifen optikailag aktív izomerei és aktív metabolitjai
SE9704644D0 (sv) New use
ATE151637T1 (de) Heterozyklische verbindungen
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
JP2005530735A5 (hu)
HK1077215A1 (en) A pharmaceutical composition for treatment of acute myocardial infarction
ITMI20020872A1 (it) Derivati dell'iperforina loro uso e formulazioni che li contengono
AR109456A2 (es) Uso de et743 para la preparación de un medicamento para el tratamiento de un paciente humano afectado por cáncer mediante terapia de combinación

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees